Internal Medicine · Dallas, TX
NPI
1811382062
Since 2015
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3500 Maple Ave. Ste 108, Methodist Medical Group SW
Dallas, TX, 75219
Phone (214) 526-3566
Groups this clinician bills Medicare through
Medicare paid, 2024
$79K
1,283 services
Medicare patients, 2024
248
Average age 73
Drug cost, 2024
$5.7M
10,855 prescriptions
Company payments, 2025
$377
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Blake D Hatfield was code 99214 (office e&m - established), 390 times for 218 patients. In total Blake D Hatfield billed 1,283 services in 36 codes, and Medicare paid $79K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 390 | 218 | $77.20 | $30K |
| 99497 Care Management/Coordination | Office | 184 | 184 | $72.36 | $13K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 172 | 172 | $127.88 | $22K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 120 | 12 | $0.07 | $8.94 |
| 99213 Office E&M - Established | Office | 79 | 67 | $58.49 | $4,621 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 78 | 70 | $11.36 | $886 |
| G0008 Administration of influenza virus vaccine | Office | 17 | 17 | $32.05 | $545 |
| 96372 Injection Administration | Office | 17 | 13 | $9.29 | $158 |
| 90662 Vaccine Product | Office | 16 | 16 | $81.82 | $1,309 |
| 93000 Electrocardiogram | Office | 11 | 11 | $8.18 | $90 |
| 82270 Immunoassay | Office | 11 | 11 | $4.29 | $47.19 |
By year: 2022 $77K for 1,106 services; 2023 $74K for 1,010 services; 2024 $79K for 1,283 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82270 Immunoassay | 11 | 11 | $4.29 | $47.19 |
Medicare prescription drug claims, 2024
In 2024, the drug Blake D Hatfield prescribed most often to Medicare patients was Rosuvastatin Calcium, with 561 prescriptions and refills. In total Blake D Hatfield wrote 10,855 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 561 | 1,562 | 160 | $5,617 |
| Atorvastatin Calcium Generic | 430 | 1,169 | 113 | $3,212 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 319 | 349 | 34 | $1.4M |
| Descovy Emtricitabine/Tenofov Alafenam | 294 | 326 | 30 | $719K |
| Lisinopril Generic | 280 | 778 | 77 | $2,102 |
| Trazodone Hcl Generic | 237 | 480 | 66 | $2,801 |
| Gabapentin Generic | 232 | 491 | 63 | $4,940 |
| Tamsulosin Hcl Generic | 215 | 558 | 53 | $2,901 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 215 | 225 | 24 | $844K |
| Losartan Potassium Generic | 208 | 557 | 57 | $1,545 |
| Amlodipine Besylate Generic | 204 | 563 | 58 | $1,361 |
| Levothyroxine Sodium Generic | 195 | 574 | 52 | $1,803 |
| Alprazolam Generic | 195 | 218 | 40 | $607 |
| Metformin Hcl Generic | 178 | 464 | 46 | $1,088 |
| Zolpidem Tartrate Generic | 159 | 267 | 33 | $1,840 |
Brand drugs: 2,323 claims; generic drugs: 8,469 claims; opioid claims: 283.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Blake D Hatfield $377 ($377 in general payments such as food, travel and fees) from 5 companies. The largest payer was Gilead Sciences, Inc. with $233.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.